about
Women and HIV in the United StatesMyocardial Recovery in Patients Receiving Contemporary Left Ventricular Assist Devices: Results From the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS).Diabetes Among People With Tuberculosis, HIV Infection, Viral Hepatitis B and C, and STDs in New York City, 2006-2010.The subgingival microbiome, systemic inflammation and insulin resistance: The Oral Infections, Glucose Intolerance and Insulin Resistance Study.Effect of CYP2C9 and VKORC1 Gene Variants on Warfarin Response in Patients with Continuous-Flow Left Ventricular Assist Devices.Discriminatory performance of positive urine hemoglobin for detection of significant hemolysis in patients with continuous-flow left ventricular assist devices.Factors Associated With Hepatitis C Infection Among HIV-Infected Men Who Have Sex With Men With No Reported Injection Drug Use in New York City, 2000-2010.Exploring the subtleties of inverse probability weighting and marginal structural models.A practical example demonstrating the utility of single-world intervention graphs.Left Ventricular Decompression During Speed Optimization Ramps in Patients Supported by Continuous-Flow Left Ventricular Assist Devices: Device-Specific Performance Characteristics and Impact on Diagnostic Algorithms.Causal language and strength of inference in academic and media articles shared in social media (CLAIMS): A systematic review.The Effects of Hepatitis C Infection and Treatment on All-cause Mortality Among People Living With Human Immunodeficiency VirusThe Effects of Hepatitis C Treatment Eligibility Criteria on All-cause Mortality Among People With Human Immunodeficiency VirusUsing Bounds to Compare the Strength of Exchangeability Assumptions for Internal and External ValidityThe Authors Respond
P50
Q36282712-4091D7F5-65F2-4AA5-A002-46613919E3F5Q37091906-1ECD513A-26D1-4970-A79E-AA638B7B69F4Q39083745-C6F3FB8E-D3BF-4C49-9327-5EC8292EEC26Q39097973-586C042E-E162-41CF-A7FB-F1D7577A3581Q39712298-AE81F61F-CCCD-4551-ABF4-EFA5AAD50592Q40489949-FED62C88-0E4F-492B-ACCE-8A3D249DEB74Q40682084-B88EC3BC-8DD9-46F9-AB1E-85AFBECBB12DQ49558465-3C797BD7-BB33-4333-B16C-FF043E4F622DQ50105908-F04BFBAD-D272-41F3-A2B9-D14C42B6CFFAQ50891881-D6307CC9-767D-46C7-8731-4ECFF2D6A6C5Q55410258-A9BC2601-2A36-41A2-8796-71088C4F2266Q57470672-2CEF60F8-4FA4-4035-8ABA-CB98225178F6Q90919231-128FB22A-2D60-4780-B628-DF23574CC3FEQ92132726-33C501B3-3013-440E-8749-03D2E82538BAQ94101409-339B13B1-8113-47E2-8B9B-0D0A0C858190
P50
description
researcher ORCID ID = 0000-0001-5568-2510
@en
wetenschapper
@nl
name
Alexander Breskin
@ast
Alexander Breskin
@en
Alexander Breskin
@es
Alexander Breskin
@nl
type
label
Alexander Breskin
@ast
Alexander Breskin
@en
Alexander Breskin
@es
Alexander Breskin
@nl
prefLabel
Alexander Breskin
@ast
Alexander Breskin
@en
Alexander Breskin
@es
Alexander Breskin
@nl
P106
P1153
56878583700
P21
P31
P496
0000-0001-5568-2510